Last updated on September 2018

Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH)

Brief description of study

The purpose of the study is to investigate whether corifollitropin alfa (MK-8962), administered in combination with human chorionic gonadotropin (hCG), increases the testicular volume in adolescent males aged 14 to <18. In addition, the study will evaluate participants for the development of corifollitropin alfa antibodies over the course of 64 weeks of treatment.

Clinical Study Identifier: NCT03019575

Contact Investigators or Research Sites near you

Start Over

Study Coordinator

Little Company of Mary Hospital ( Site 0017)
Pretoria, South Africa
  Connect »